25023062 Visualization
Back to Main Page
A
66
Age
-
year
Age
-
old
Age
Caucasian
Personal_background
woman
Sex
with a history of
hypertension
History
was
admitted
Clinical_event
to our
hospital
Nonbiological_location
with a recent diagnosis of
Burkitt
Disease_disorder
lymphoma
Disease_disorder
.Her
lactate
Diagnostic_procedure
dehydrogenase
Diagnostic_procedure
level was
high
Qualitative_concept
and the diameter of her
mediastinal
Biological_structure
mass
Sign_symptom
was
more
Distance
than
Distance
10cm
Distance
.Her
physical
Diagnostic_procedure
examination
Diagnostic_procedure
was
normal
Lab_value
, and
basal
Detailed_description
electrocardiography
Diagnostic_procedure
(
ECG
Diagnostic_procedure
) showed
sinus
Sign_symptom
rhythm
Sign_symptom
with a
heart
Diagnostic_procedure
rate
Diagnostic_procedure
of
72
Lab_value
beats/minute
Lab_value
.
Two
Diagnostic_procedure
-
dimensional
Diagnostic_procedure
transthoracic
Diagnostic_procedure
echocardiography
Diagnostic_procedure
(
TTE
Diagnostic_procedure
;
Siemens
Detailed_description
,
Acuson
Detailed_description
Sequoia
Detailed_description
,
C512
Detailed_description
) revealed
normal
Lab_value
biventricular
Diagnostic_procedure
functions
Diagnostic_procedure
with an
LV
Diagnostic_procedure
ejection
Diagnostic_procedure
fraction
Diagnostic_procedure
(
LVEF
Diagnostic_procedure
) of
60%
Lab_value
,
mild
Severity
mitral
Biological_structure
and
tricuspid
Biological_structure
regurgitation
Sign_symptom
, and
moderate
Severity
pericardial
Sign_symptom
effusion
Sign_symptom
.A
risk
Diagnostic_procedure
assessment
Diagnostic_procedure
of the patient put her into a
high
Qualitative_concept
-
risk
Qualitative_concept
category and she underwent
rituximab
Medication
-
hyperfractionated
Medication
-
cyclophosphamide
Medication
-
vincristine
Medication
-
doxorubicin
Medication
-
dexamethasone
Medication
(
R
Medication
-
Hyper
Medication
-
CVAD
Medication
)
chemotherapy
Medication
protocol.Her
laboratory
Diagnostic_procedure
values
Diagnostic_procedure
are summarized in Table 1.She received
high
Dosage
-
dose
Dosage
cyclophosphamide
Medication
300mg/m2
Dosage
twice
Dosage
daily
Dosage
for
3
Duration
days
Duration
,
doxorubicin
Medication
25mg/m2/day
Dosage
for
2
Duration
days
Duration
,
rituximab
Medication
375mg/m2/day
Dosage
for
1
Duration
day
Duration
,
dexamethasone
Medication
40mg/day
Dosage
for
4
Duration
days
Duration
, and
vincristine
Medication
2mg/day
Dosage
for
2
Duration
days
Duration
.The total treatment dose of
cyclophosphamide
Medication
and
doxorubicin
Medication
received was
1800mg/m2
Dosage
and
50mg/m2
Dosage
, respectively.She was given
allopurinol
Medication
300mg/day
Dosage
perorally
Administration
,
sodium
Medication
bicarbonate
Medication
(
8.4%
Dosage
,
10
Dosage
flacon/day
Dosage
)
infusion
Administration
for
24
Duration
hours
Duration
before
Duration
chemotherapy
Medication
, and
mesna
Medication
600mg/m2/day
Dosage
for
2
Duration
days
Duration
as
prophylaxis
Therapeutic_procedure
against
tumor
Disease_disorder
lysis
Disease_disorder
syndrome
Disease_disorder
and
hemorrhagic
Disease_disorder
cystitis
Disease_disorder
, respectively.She also received
granisetron
Medication
2mg/day
Dosage
and
lansoprazole
Medication
30mg/day
Dosage
as
antiemetogenic
Detailed_description
and
gastric
Biological_structure
prophylaxis
Therapeutic_procedure
, respectively.The patient developed
dyspnea
Sign_symptom
on the
seventh
Date
day
Date
of therapy.A
physical
Diagnostic_procedure
examination
Diagnostic_procedure
revealed
blood
Diagnostic_procedure
pressure
Diagnostic_procedure
of
100/60mmHg
Lab_value
and a
heart
Diagnostic_procedure
rate
Diagnostic_procedure
of
110
Lab_value
beats/minute
Lab_value
.On
chest
Biological_structure
auscultation
Diagnostic_procedure
, no
inspiratory
Sign_symptom
sounds
Sign_symptom
were heard at
lower
Biological_structure
zones
Biological_structure
and
inspiratory
Sign_symptom
crackles
Sign_symptom
were heard at
middle
Biological_structure
zones
Biological_structure
.Neither
cardiac
Sign_symptom
murmurs
Sign_symptom
nor
S3
Sign_symptom
were heard.An
ECG
Diagnostic_procedure
showed
low
Lab_value
voltage
Lab_value
in the
limb
Diagnostic_procedure
and
Diagnostic_procedure
precordial
Diagnostic_procedure
leads
Diagnostic_procedure
.
TTE
Diagnostic_procedure
showed
diffusely
Lab_value
increased
Lab_value
myocardial
Biological_structure
echogenicity
Diagnostic_procedure
,
mild
Severity
pericardial
Sign_symptom
effusion
Sign_symptom
, and
generally
Lab_value
impaired
Lab_value
biventricular
Detailed_description
systolic
Diagnostic_procedure
functions
Diagnostic_procedure
with an
LVEF
Diagnostic_procedure
31%
Lab_value
and
right
Biological_structure
ventricular
Biological_structure
mid
Detailed_description
-
apical
Detailed_description
akinesis
Sign_symptom
.
Manifest
Detailed_description
pleural
Sign_symptom
effusion
Sign_symptom
was also detected.
Drug
Disease_disorder
-
induced
Disease_disorder
cardiotoxicity
Disease_disorder
(
myocarditis
Disease_disorder
) was suspected.
Furosemide
Medication
and
ramipril
Medication
were started.The
beta
Medication
-
blocker
Medication
therapy the patient was already taking for
hypertension
Sign_symptom
was continued.
After
Date
12
Date
days
Date
,
TTE
Diagnostic_procedure
showed an
LVEF
Diagnostic_procedure
of
37%
Lab_value
and
normal
Lab_value
right
Diagnostic_procedure
ventricular
Diagnostic_procedure
functions
Diagnostic_procedure
.Her
dyspnea
Sign_symptom
decreased and she was
discharged
Activity
on
day
Date
20
Date
.
After
Date
1
Date
month
Date
,
TTE
Diagnostic_procedure
showed
normal
Lab_value
biventricular
Diagnostic_procedure
functions
Diagnostic_procedure
with an
LVEF
Diagnostic_procedure
of
60%
Lab_value
.After the first course of the
R
Medication
-
Hyper
Medication
-
CVAD
Medication
chemotherapy
Medication
protocol, she underwent a
high
Dosage
-
dose
Dosage
methotrexate
Medication
and
cytarabine
Medication
cycle.She had severe
neutropenia
Sign_symptom
and
pneumonia
Disease_disorder
.She had no
cardiac
Sign_symptom
failure
Sign_symptom
symptoms
Sign_symptom
during this
chemotherapy
Medication
course, but she declined
another
Detailed_description
course
Detailed_description
of
chemotherapy
Medication
.She is still in
remission
Sign_symptom
despite the abbreviated course of
chemotherapy
Medication
.